IDYA
IDEAYA Biosciences, Inc.
NASDAQ · Healthcare · Biotechnology · US
$39.99
+0.05%Margins
Gross margin
-13.3%
EBITDA margin
-90.7%
EBIT margin
-92.7%
Net margin
-74.8%
FCF margin
-81.2%
-14.6%
Return on equity
-13.4%
Return on assets
-17.7%
Return on invested capital
0.20x
Asset turnover
-$186.8M
Cash from operations
$8.59
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026